VYG-EFB-300

VYG-EFB-300 is a diagnostic contrast agent under development by Voyageur Pharmaceuticals, specifically designed for use in radiology and CT imaging procedures. As a contrast medium, it functions by increasing the radiopacity of the areas it occupies, thereby allowing for clearer visualization of internal structures and aiding in medical diagnosis. Voyageur Pharmaceuticals is developing this product as part of a broader suite of barium and iodine-based imaging agents, leveraging their own mineral sources to ensure a stable supply chain for the diagnostic imaging market. The product is intended to improve the diagnostic accuracy of radiographic examinations by enhancing the contrast of images produced during these procedures.